Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
James T. Treace currently holds 1,223,441 shares of TREACE MEDICAL CONCEPTS, INC. (TMCI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James T. Treace has been a net seller of TMCI stock. They have purchased $2.1M and sold $29.2M worth of shares.
James T. Treace's most recent insider trade was on Aug 15, 2024, when they purchased 84,000 shares at $5.96 per share.
James T. Treace serves as Executive at TREACE MEDICAL CONCEPTS, INC. (TMCI). They have executed 109 insider transactions totaling $31.3M over their tenure at the company.
James T. Treace holds the position of Executive at TREACE MEDICAL CONCEPTS, INC., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
James T. Treace has shown a selling trading pattern, with $2.1M in total purchases and $29.2M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by James T. Treace was on Mar 30, 2023, when they sold $1.3M worth of TMCI shares. This transaction involved 50,000 shares at $25.86 per share.
James T. Treace currently owns 1,223,441 shares of TREACE MEDICAL CONCEPTS, INC. (TMCI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of James T. Treace's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. James T. Treace has 109 Form 4 filings on record as an insider at TREACE MEDICAL CONCEPTS, INC..
Set alerts for James T. Treace and 40,000+ other insiders.